<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to determine the occurrence and clinical value of anticardiolipin antibodies in patients with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty one patients with primary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> women, mean (SD) age 48.3 (11.2) years) and 32 patients with secondary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (<z:hpo ids='HP_0000001'>all</z:hpo> women, mean (SD) age 54.9 (11) years) were studied </plain></SENT>
<SENT sid="2" pm="."><plain>IgG, IgM, and IgA anticardiolipin antibodies were determined by a standard enzyme linked immunosorbent assay (ELISA) technique </plain></SENT>
<SENT sid="3" pm="."><plain>Anticardiolipin antibodies were found in five patients (16%) with primary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> and in seven patients (22%) with secondary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>There was no correlation between anticardiolipin antibodies and the clinical features of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (thrombotic events, fetal loss, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>) or extraglandular manifestations of <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> (<z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:mp ids='MP_0001212'>skin lesions</z:mp>, <z:hpo ids='HP_0100614'>myositis</z:hpo>, <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo>, central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">disease, pulmonary</z:e> and <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e>) in either group </plain></SENT>
<SENT sid="5" pm="."><plain>Among the various serological features studied, anticardiolipin antibodies correlated with <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo> and antibodies to RNP only in patients with primary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These results indicate that although anticardiolipin antibodies are often found in serum samples from patients with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e>, their clinical significance remains unclear </plain></SENT>
</text></document>